Brewin Dolphin Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$19K Hold
300
﹤0.01% 241
2022
Q1
$18K Hold
300
﹤0.01% 260
2021
Q4
$22K Hold
300
﹤0.01% 253
2021
Q3
$21K Hold
300
﹤0.01% 259
2021
Q2
$20.7K Hold
300
﹤0.01% 263
2021
Q1
$19.4K Hold
300
﹤0.01% 256
2020
Q4
$17.5K Sell
300
-140
-32% -$8.45K ﹤0.01% 232
2020
Q3
$27.8K Buy
440
+300
+214% +$20.8K 0.01% 200
2020
Q2
$10.8K Sell
140
-3,570
-96% -$274K ﹤0.01% 249
2020
Q1
$277K Hold
3,710
0.15% 64
2019
Q4
$241K Sell
3,710
-250
-6% -$16.3K 0.11% 68
2019
Q3
$251K Sell
3,960
-400
-9% -$26.1K 0.13% 65
2019
Q2
$295K Sell
4,360
-240
-5% -$15.8K 0.15% 63
2019
Q1
$299K Sell
4,600
-300
-6% -$19.9K 0.16% 64
2018
Q4
$306K Hold
4,900
0.19% 62
2018
Q3
$378K Sell
4,900
-540
-10% -$40.8K 0.2% 59
2018
Q2
$385K Sell
5,440
-550
-9% -$38.8K 0.23% 58
2018
Q1
$452K Sell
5,990
-4,300
-42% -$342K 0.28% 53
2017
Q4
$737K Hold
10,290
0.47% 38
2017
Q3
$834K Buy
+10,290
New +$787K 0.58% 36

Other funds holding GILD

Brewin Dolphin Wealth Management's GILD Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2022 at 300 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Brewin Dolphin Wealth Management first reported a position in GILD in Q3 2017 and has held it in 20 quarters since. The position peaked at $834K in Q3 2017. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Brewin Dolphin Wealth Management held 300 shares of Gilead Sciences worth $19K as of Q2 2022.
  • Brewin Dolphin Wealth Management left its Gilead Sciences share count unchanged in Q2 2022.
  • Gilead Sciences made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #241 holding.
  • Brewin Dolphin Wealth Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 20 quarters since.
  • Brewin Dolphin Wealth Management's Gilead Sciences position peaked at $834K in Q3 2017.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.